Indeed, this peptide vaccine was shown to reduce plasma levels of PCPE-1 (Fig. 3K) and produce a significant reduction in liver fibrosis (Figs. 3L,M and EV3L). The gene discussed is PCOLCE; the disease is Hepatic fibrosis.